Antireflux Mucosectomy, Mucosal Ablation Compared for GERD
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 5, 2024 -- For patients with gastroesophageal reflux disease (GERD), improvement in symptoms is seen with both antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA), but subjective and objective indicators of outcomes are better with ARMS than ARMA, according to a study published online June 21 in Digestive Endoscopy.
Ah Young Lee, M.D., Ph.D., from Cha University in Seoul, South Korea, and colleagues compared the efficacy and safety of ARMS and ARMA for GERD in a multicenter, retrospective, observational study including 274 patients (96 underwent ARMA and 178 underwent ARMS). The primary outcome was subjective symptom improvement, which was based on the GERD questionnaire (GERDQ).
The researchers found that compared with the ARMA group, baseline GERDQ scores were higher in the ARMS group (10.0 versus 8.0) and there was a greater median postprocedure improvement observed (4.0 versus 2.0), even after propensity score matching. There was significant improvement seen in reflux esophagitis in ARMS versus ARMA, with notable changes seen in Los Angeles grade and flap valve grade scores. Comparable improvement in Barrett esophagus was seen between the groups, with 94.7 and 77.8 percent resolution rates noted in the ARMS and ARMA groups, respectively. The ARMS group experienced higher bleeding rates than the ARMA group, along with comparable stricture rates and more proton pump withdrawals.
"Both ARMA and ARMS are advantageous because they do not require specialized equipment, are relatively inexpensive, and can be easily performed anywhere," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
FRIDAY, July 11, 2025 -- Consistently and increasingly accumulated physical activity (PA) is associated with a reduced risk for all-cause and cardiovascular disease (CVD)...
Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults
THURSDAY, July 10, 2025 -- Use of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased liver enzyme levels, according...
Majority of Patients With Lyme Disease Do Not Follow Up With Clinician
THURSDAY, July 10, 2025 -- Only 34 percent of patients with erythema migrans >5 cm are positive for Lyme disease by a standard two-tier testing (STTT) algorithm, and of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.